Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Atherosclerosis. 2021 Nov 5;338:15–22. doi: 10.1016/j.atherosclerosis.2021.11.002

Table 3.

Multivariable-adjusted association between adipokines and ECC extent.

Model 1 Model 2 Model 2b Model 3 Model 3b
Aortic Valve Calcium (AVC)
Leptin 1.07 (0.98, 1.16) 0.99 (0.89, 1.11) 0.94 (0.82, 1.07) 0.95 (0.85, 1.07) 0.91 (0.79, 1.04)
Resistin 1.03 (0.96, 1.10) 1.01 (0.94, 1.09) 1.01 (0.93, 1.09) 0.99 (0.92, 1.06) 0.99 (0.91, 1.07)
Adiponectin 0.89 (0.83, 0.96) 0.90 (0.83, 0.97) 0.93 (0.85, 1.02) 0.92 (0.84, 1.00) 0.95 (0.86, 1.05)
Leptin/adiponectin 1.10 (1.02, 1.19) 1.07 (0.97, 1.18) 1.01 (0.89, 1.14) 1.02 (0.92, 1.13) 0.97 (0.86, 1.09)
Resistin/adiponectin 1.11 (1.03, 1.19) 1.10 (1.02, 1.19) 1.06 (0.97, 1.16) 1.06 (0.98, 1.15) 1.03 (0.94, 1.13)
Mitral annular calcium (MVC)
Leptin 1.11 (1.02, 1.21) 1.00 (0.89, 1.13) 0.99 (0.86, 1.13) 1.01 (0.90, 1.14) 1.00 (0.87, 1.14)
Resistin 1.06 (0.98, 1.13) 1.04 (0.97, 1.12) 1.01 (0.93, 1.09) 1.04 (0.96, 1.12) 1.01 (0.93, 1.10)
Adiponectin 1.00 (0.92, 1.08) 1.04 (0.96, 1.13) 0.99 (0.90, 1.09) 1.03 (0.95, 1.13) 0.98 (0.89, 1.08)
Leptin/Adiponectin 1.08 (1.00, 1.17) 0.98 (0.88, 1.08) 1.00 (0.88,1.13) 0.99 (0.89,1.10) 1.01 (0.90, 1.15)
Resistin/adiponectin 1.04 (0.96, 1.12) 1.00 (0.92, 1.08) 1.01 (0.93, 1.11) 1.00 (0.92, 1.09) 1.03 (0.93, 1.13)
Ascending thoracic aortic calcium (ATAC)
Leptin 1.01 (0.96, 1.07) 1.03 (0.96, 1.10) 0.99 (0.91, 1.08) 1.01 (0.94, 1.08) 0.98 (0.90, 1.07)
Resistin 1.06 (1.02, 1.11) 1.07 (1.02, 1.11) 1.03 (0.98, 1.09) 1.06 (1.02, 1.11) 1.03 (0.98, 1.08)
Adiponectin 0.98 (0.93, 1.02) 0.98 (0.93, 1.03) 1.00 (0.94, 1.05) 1.00 (0.95, 1.05) 1.01 (0.95, 1.07)
Leptin/Adiponectin 1.02 (0.97, 1.07) 1.03 (0.97, 1.10) 1.00 (0.93, 1.07) 1.01 (0.95, 1.07) 0.98 (0.91, 1.06)
Resistin/Adiponectin 1.06 (1.01, 1.10) 1.06 (1.01, 1.11) 1.03 (0.97, 1.08) 1.05 (1.00, 1.10) 1.02 (0.96, 1.08)
Descending thoracic aortic calcium (DTAC)
Leptin 1.09 (0.96, 1.23) 1.11 (0.94, 1.32) 1.14 (0.93, 1.40) 1.04 (0.88, 1.23) 1.09 (0.89, 1.34)
Resistin 1.13 (1.01, 1.26) 1.11 (1.00, 1.24) 1.12 (0.99, 1.26) 1.07 (0.96, 1.19) 1.08 (0.96, 1.22)
Adiponectin 0.93 (0.83, 1.04) 0.93 (0.82, 1.05) 0.93 (0.81, 1.08) 0.98 (0.87, 1.12) 0.99 (0.86, 1.15)
Leptin/Adiponectin 1.10 (0.98, 1.23) 1.13 (0.97, 1.31) 1.15 (0.96, 1.38) 1.04 (0.90, 1.21) 1.07 (0.89, 1.28)
Resistin/Adiponectin 1.14 (1.02, 1.28) 1.14 (1.02, 1.28) 1.14 (1.00, 1.31) 1.07 (0.95, 1.21) 1.07 (0.93, 1.23)
a

Results were derived from multivariable linear regression models and presented as exponentiated beta coefficients.

b

Adipokines were log-transformed for analysis and compared per 1 standard deviation (SD).

c

Extra-coronary calcium (ECC) was log-transformed and evaluated continuously as Log (ECC +1).

d

Model 1: adjusted for age, sex, race/ethnicity and study site

e

Model 2: Model 1 + education, body mass index, smoking, pack years of smoking, and physical activity.

f

Model 2b: Model 2 + visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT).

g

Model 3: Model 2 + systolic blood pressure, anti-hypertensive medication, total cholesterol, HDL-cholesterol, lipid-lowering medication, diabetes mellitus and eGFR.

h

Model 3b: Model 3: VAT and SAT.

i

Statistically significant results are in bold font. p value = 0.047 for result in italics.